• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.62% Nasdaq Up0.35%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    67.02 Up 1.91(2.93%) Feb 10, 4:00PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 208,172   250,523   203,264   231,824  
    Cost of Revenue36,719  39,878  32,813  45,818  
    Gross Profit 171,453   210,645   170,451   186,006  
    Operating Expenses
    Research Development158,713  157,901  142,074  142,067  
    Selling General and Administrative94,044  101,514  92,806  99,768  
    Non Recurring -   -   -   -  
    Others616  15,471  1,431  2,927  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (81,920) (64,241) (65,860) (58,756)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,110  (8,097)769  1,991  
    Earnings Before Interest And Taxes(80,996)(72,541)(65,241)(56,540)
    Interest Expense9,447  10,002  9,462  9,197  
    Income Before Tax(90,443)(82,543)(74,703)(65,737)
    Income Tax Expense483  (554)(7,202)4,060  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(91,112)(82,192)(67,651)(69,572)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (90,926) (81,989) (67,501) (69,797)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (90,926) (81,989) (67,501) (69,797)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.